Cargando…

Predictive biomarkers for negative symptoms in schizophrenia

INTRODUCTION: Increasing evidence shows that impaired neuroplasticity and high inflammation play a crucial role in the pathophysiology of schizophrenia. Prospective studies demonstrated that patients with high inflammation usually have a poor treatment response and clinical practice learns that nega...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cakici, N., Haan, L. De, Beveren, N. Van
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2021
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471742/ http://dx.doi.org/10.1192/j.eurpsy.2021.369

Ejemplares similares

Marker of schizophrenia with enduring negative symptoms
por: Dmitrieva, E., et al.
Publicado: (2022)

Changes in peripheral blood compounds following psychopharmacological treatment in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis
por: Çakici, Nuray, et al.
Publicado: (2021)

The structure stability of negative symptoms: longitudinal network analysis of the Brief Negative Symptom Scale in subjects with schizophrenia
por: Caporusso, E., et al.
Publicado: (2023)

Negative symptoms of schizophrenia in patients with acute and transient psychotic disorders
por: Aleshkina, G., et al.
Publicado: (2021)

Negative and Cognitive Symptoms of Schizophrenia: Are there Adequate Pharmacological Treatments?
por: Vasiliu, O.
Publicado: (2022)

Negative symptoms and associated factors in older people with schizophrenia
por: Karoui, M., et al.
Publicado: (2023)

Immune-related genes are differentially associated with negative symptoms subdomains in patients with schizophrenia
por: Golimbet, V., et al.
Publicado: (2022)

Relation between Negative Symptoms and Core Stability as an Indicator of Functional Exercise Capacity in Schizophrenia
por: Hoşgelen, E. I., et al.
Publicado: (2023)

Therapeutic effect of qinghuanling on negative symptoms and cognitive function of schizophrenia
por: Zhang, Y., et al.
Publicado: (2021)

T100. NICOTINE USE IMPACTS NEGATIVE SYMPTOMS SEVERITY IN SCHIZOPHRENIA
por: Oliveira, Hianna, et al.
Publicado: (2018)

An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis
por: Çakici, N., et al.
Publicado: (2019)

A Visual Metaphor Describing Neural Dynamics in Schizophrenia
por: van Beveren, Nico J. M., et al.
Publicado: (2008)

Resting-state brain activity dysfunctions in schizophrenia and their associations with negative symptom domains
por: Pezzella, P., et al.
Publicado: (2023)

T46. TARGETING THE IMMUNE SYSTEM TO TREAT DEPRESSION AND NEGATIVE SYMPTOMS IN SCHIZOPHRENIA
por: Krynicki, Carl, et al.
Publicado: (2018)

F225. LEVODOPA AUGMENTATION OF ANTIPSYCHOTICS FOR THE TREATMENT OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA
por: Foussias, George, et al.
Publicado: (2018)

Negative symptoms in first episode schizophrenia: Results from the “parma early psychosis” program
por: Pelizza, L., et al.
Publicado: (2021)

PM521. Relationship between Negative Symptoms and Social Cognition in Patient with Schizophrenia
por: Hyun, Jiewon, et al.
Publicado: (2016)

A case report of inhibition and severe desnutrition: negative symptoms in resistant schizophrenia
por: Coucheiro Limeres, P., et al.
Publicado: (2022)

The relationship between the recognition of specific basic emotions and negative symptom domains in patients with schizophrenia spectrum disorders
por: Zierhut, M., et al.
Publicado: (2022)

Metacognition, symptoms and general functioning in patients with schizophrenia
por: Daoud, M., et al.
Publicado: (2021)

Negative symptoms and social and occupational functioning differentiate systematic paraphrenia from schizophrenia: results from a cross-sectional study
por: Fernandes, L.A., et al.
Publicado: (2022)

The Brief Negative Symptom Scale: external validation of symptom domains with clinical, cognitive and functioning-related variables in subjects with schizophrenia
por: Giordano, G. M., et al.
Publicado: (2023)

Resting-state functional connectivity of the ventral tegmental area and negative symptom domains in subjects with schizophrenia
por: Pezzella, P., et al.
Publicado: (2021)

F83. INVESTIGATING THE RELATIONSHIP BETWEEN NEGATIVE SYMPTOM PROFILE AND COGNITIVE FUNCTION IN SCHIZOPHRENIA
por: Yolland, Caitlin, et al.
Publicado: (2018)

T154. RESTING STATE PERFUSION IN THE REWARD SYSTEM LINKED TO DIMENSIONS OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA
por: Stegmayer, Katharina, et al.
Publicado: (2018)

S213. CAN PATIENTS WITH TREATMENT RESISTANT SCHIZOPHRENIA RELIABLY REPORT NEGATIVE SYMPTOMS? A PILOT STUDY USING THE SELF-EVALUATION OF NEGATIVE SYMPTOMS SCALE
por: Lindenmayer, Jean-Pierre, et al.
Publicado: (2018)

Assessment of obsessive and compulsive symptoms in patients with schizophrenia
por: Ajmi, S., et al.
Publicado: (2022)

Assessment of depressive symptoms in hospitalized patients with schizophrenia
por: Abdelkefi, M., et al.
Publicado: (2022)

Predictive value of body composition and core symptoms in schizophrenia for cardiorespiratory fitness: CORTEX-SP study
por: Tous-Espelosin, M., et al.
Publicado: (2022)

NEGATIVE SYMPTOMS AND NEGATIVE SCHIZOPHRENIA
por: Chaturvedi, S.K., et al.
Publicado: (1984)

T51. TREATMENT OF NEGATIVE SYMPTOMS OF SCHIZOPHRENIA WITH TRANSCRANIAL CURRENT STIMULATION (TDCS): RESULTS OF RANDOMIZED, DOUBLE-BLINDED, SHAM-CONTROLLED TRIAL
por: Valiengo, Leandro, et al.
Publicado: (2018)

F164. VENTRAL AND DORSAL STRIATAL DYSFUNCTION DURING REWARD ANTICIPATION IS ASSOCIATED WITH NEGATIVE SYMPTOMS IN PATIENTS WITH SCHIZOPHRENIA AND HEALTHY INDIVIDUALS
por: Stepien, Marta, et al.
Publicado: (2018)

Primary and Secondary Negative Symptoms in Schizophrenia
por: Mosolov, Sergey N., et al.
Publicado: (2022)

S216. REDUCED EMOTIONAL FACIAL EXPRESSION IN SCHIZOPHRENIA – A PROBE INTO THE PHENOMENOLOGY AND RELEVANCE OF EXPRESSIVE NEGATIVE SYMPTOMS
por: Riehle, Marcel, et al.
Publicado: (2018)

Negative symptoms in schizophrenia
por: Mitra, Sayantanava, et al.
Publicado: (2016)

Evidence for disturbed insulin and growth hormone signaling as potential risk factors in the development of schizophrenia
por: van Beveren, N J M, et al.
Publicado: (2014)

Combination of clozapine, cariprazine and fluoxetine in treatment-resistant schizophrenia patient with prominent negative symptoms: A Case report
por: Everte, I., et al.
Publicado: (2022)

Relationship between CAINS negative symptoms and cognition, psychosocial functioning and quality of life in patients with a first psychotic episode of schizophrenia
por: Rodriguez-Jimenez, R., et al.
Publicado: (2023)

O11.3. A LONGITUDINAL ANALYSIS OF THE EFFECTS OF NEUROTICISM AND EXTRAVERSION ON SUBJECTIVE WELL-BEING IN PATIENTS WITH SCHIZOPHRENIA
por: van Dijk, Floor, et al.
Publicado: (2018)

Dataset on negative symptoms factors in patients with schizophrenia
por: Lezheiko, T.V., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fnmkpp7ogfquqlm2jgrkl0bto0